| abstract |
When the cytokine is TNFα, TNFβ, or IFNγ, the tumor targeting moiety (TTM) is other than CD13 ligand, when the cytokine is IL12, TTM is other than an antibody against fibronectin, and when the cytokine is TNF, A complex of cytokine and TTM, provided that the TTM is other than an antibody against the transferrin receptor, and when the cytokine is TNF, IFNγ or IL2, the antibody is other than an antibody against the TAG72 antigen. |